Oncolytic Viruses Articles & Pharmaceutical Insights | Pharma’s Almanac

Subscribe

Subscribe for the Newsletter

Mobile Navigation

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Market Research

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Oncolytic Viruses

Sort By

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us Nice Insight That's Nice

Reach Our Team

Contact Us Advertise LinkedIn

My Account

Subscribe for the newsletter

© 2026 PHARMA'S ALMANAC. All rights reserved.

Privacy Policy Terms And Conditions

(2)

1 / 1

Oncolytic Viruses at a Turning Point: Advancing Olvi-Vec for Advanced Ovarian Cancer

Ovarian Cancer

Oncolytic Viruses at a Turning Point: Advancing Olvi-Vec for Advanced Ovarian Cancer

David Alvaro, Ph.D.; Jason Litten, M.D.

Pharma's Almanac

PAO-04-26-CL-03Apr 21, 2026

Oncolytic Virotherapy: Real Potential and Difficult Challenges

Virotherapy

Oncolytic Virotherapy: Real Potential and Difficult Challenges

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-12-24-CL-1Dec 2, 2024

1 / 1